Ginger Vieira
Author, Writer and Editor at Freelance
Author, freelancer & YouTuber! Living with type 1 diabetes since 1999. Find my books on Amazon and my videos on https://t.co/RiEvCHQBQB!
Articles
-
Dec 14, 2024 |
diabetesdaily.com | Ginger Vieira
Imagine this: an insulin that responds to blood sugar changes. An insulin that works when you need it and turns off when you don’t. Drugmakers have been working on a so-called “smart insulin” for decades. A smart insulin could allow people with diabetes to more aggressively target normal blood sugar levels. It could reduce the risk of both hypoglycemia and hyperglycemia, leading to better health outcomes in both the short and long term.
-
Dec 2, 2024 |
diabetesdaily.com | Ginger Vieira
If you live with type 2 diabetes, you may want to mind your muscles. Your muscles play a vital role in your metabolism. The muscles are the largest organ in the body, and they remove more sugar from your bloodstream than the rest of your organs combined. The health of the muscles significantly impacts the development and progression of diabetes. Unfortunately, many people with type 2 diabetes experience muscle atrophy (loss), which shares risk factors with diabetes itself.
-
Nov 19, 2024 |
diabetesdaily.com | Ginger Vieira
Imagine if there was a medication you could take every day that protected you from low blood sugar (hypoglycemia). A drug that only worked when you needed it. Zucara Therapeutics, a Toronto firm founded in 2014, is developing a drug that may protect adults living with type 1 diabetes from nighttime lows. Today, they are recruiting participants for their new clinical trial.
-
Nov 2, 2024 |
diabetesdaily.com | Ginger Vieira
Automated insulin delivery (AID) systems, also known as closed loops, are changing the way we manage type 1 diabetes. These systems, which unite an insulin pump with a continuous glucose monitor (CGM), automatically select how much insulin you need, continually adjusting dosing throughout the day, based on how high or low your blood glucose gets. Some experts believe that almost everybody with type 1 diabetes should be using an AID system — and that they should all start as soon as they can.
-
Oct 31, 2024 |
diabetesdaily.com | Ginger Vieira
The Eversense 365 Continuous Glucose Monitor (CGM) is the first of its kind: an implantable continuous glucose monitor that works for an entire year and is approved for use in people with type 1 and type 2 diabetes. Unlike competing CGMs, which stick to your skin for 14 days or less at a time, the Eversense sensor is surgically implanted under the skin, where it can stay for a year. Insertion only takes about 10 minutes.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 8K
- Tweets
- 18K
- DMs Open
- No
https://t.co/MfH9kctqTP Join us in this exciting video as we dive into TixiMed's groundbreaking research aimed at curing type 1 diabetes (T1D)! Discover the innovative approaches and cutting-edge technologies being developed by TixiMed's team of experts. We’ll explore how their
Read here 🔗👇 https://t.co/NMOVhEytPi
Got a Tandem t:slim X2 pump? Don’t sleep on the features! 💡 If you’re using the tech, use it fully. Basal IQ, Control IQ, temp rates — it’s more than just a delivery device. Learning how to make the most of your pump can make a real difference in day-to-day life with t1d. ... https://t.co/Ufok1N3hqH